Quadrant Capital Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$554K Buy
2,295
+746
+48% +$180K 0.02% 805
2025
Q1
$377K Buy
1,549
+1,500
+3,061% +$365K 0.01% 934
2024
Q4
$16.1K Buy
49
+20
+69% +$6.57K ﹤0.01% 1977
2024
Q3
$9.7K Buy
29
+4
+16% +$1.34K ﹤0.01% 2153
2024
Q2
$6.83K Sell
25
-101
-80% -$27.6K ﹤0.01% 2222
2024
Q1
$43.6K Buy
126
+51
+68% +$17.6K ﹤0.01% 1473
2023
Q4
$24.2K Buy
75
+45
+150% +$14.5K ﹤0.01% 1727
2023
Q3
$10.8K Sell
30
-14
-32% -$5.02K ﹤0.01% 1966
2023
Q2
$16.7K Sell
44
-137
-76% -$51.9K ﹤0.01% 1804
2023
Q1
$86.7K Buy
181
+35
+24% +$16.8K 0.01% 921
2022
Q4
$61.4K Buy
146
+61
+72% +$25.7K 0.01% 1049
2022
Q3
$35K Sell
85
-65
-43% -$26.8K ﹤0.01% 1233
2022
Q2
$74K Sell
150
-4
-3% -$1.97K 0.01% 750
2022
Q1
$87K Hold
154
0.01% 726
2021
Q4
$116K Buy
154
+12
+8% +$9.04K 0.01% 604
2021
Q3
$106K Buy
142
+8
+6% +$5.97K 0.01% 601
2021
Q2
$86K Sell
134
-2
-1% -$1.28K 0.01% 655
2021
Q1
$78K Buy
136
+9
+7% +$5.16K 0.01% 664
2020
Q4
$74K Sell
127
-4
-3% -$2.33K 0.01% 606
2020
Q3
$68K Buy
131
+68
+108% +$35.3K 0.01% 552
2020
Q2
$28K Sell
63
-229
-78% -$102K 0.01% 926
2020
Q1
$103K Buy
292
+19
+7% +$6.7K 0.02% 572
2019
Q4
$96K Hold
273
0.01% 999
2019
Q3
$87K Buy
273
+169
+163% +$53.9K 0.01% 946
2019
Q2
$29K Hold
104
﹤0.01% 1462
2019
Q1
$29K Buy
104
+70
+206% +$19.5K 0.01% 1402
2018
Q4
$5K Buy
34
+9
+36% +$1.32K ﹤0.01% 1625
2018
Q3
$6K Hold
25
﹤0.01% 1477
2018
Q2
$6K Hold
25
﹤0.01% 1481
2018
Q1
$6K Hold
25
﹤0.01% 1455
2017
Q4
$3K Hold
25
﹤0.01% 1626
2017
Q3
$3K Buy
25
+8
+47% +$960 ﹤0.01% 1619
2017
Q2
$1K Hold
17
﹤0.01% 1701
2017
Q1
$2K Buy
17
+4
+31% +$471 ﹤0.01% 1571
2016
Q4
$1K Hold
13
﹤0.01% 1639
2016
Q3
$1K Hold
13
﹤0.01% 1622
2016
Q2
$1K Hold
13
﹤0.01% 1592
2016
Q1
$1K Buy
13
+3
+30% +$231 ﹤0.01% 1458
2015
Q4
$1K Hold
10
﹤0.01% 1420
2015
Q3
$1K Buy
10
+5
+100% +$500 ﹤0.01% 1048
2015
Q2
$0 Buy
+5
New ﹤0.01% 1234